Back to the overview
Agent passport

Apollo Hospitals AICOPD

Apollo Hospitals Enterprise Ltd · Operations & Productivity

SaaSNo attestation published

Certification per Microsoft Marketplace.

An AI-based Risk Score (AICOPD) to predict acute exacerbations of asthma and COPD-related eventsacute exacerbations of asthma and COPD-related events.
Provenance reach4 of 12 layers traced

Evidence tier Source Confirmed · 8 captures on record

User ratingNot rated0 reviews on the listing
Runs onSaaSSaaS
ProvenanceUnknown44% of the provenance layers this product can disclose
Evidence riskHighSign in to see the basis for this band.

What the publisher says

As described on Microsoft Marketplace.

  • A machine learning model developed using

Indian data demonstrates higher accuracy compared to conventional risk scores.

Show the rest of the publisher’s description (22 more lines)
  • Feedback Loop from the

prospective use in patients

  • Comprehensive & Holistic

Risk Assessment

  • Validated at different

National Institutions

  • Integrated Clinical Decision

Support Tool (What Next to Do)

  • QMS: ISO

13485:2016 and MDSAP certified

Interpretation & Adoption Message

  • AI Algorithm + Clinicians: This risk assessment tool has

been built as an adjunct tool for physicians to identify the global/holistic

risk for patients developing acute exacerbations of asthma or COPD-related events in the next 90 days.

  • Risk Identification and Prevention: This risk assessment

tool is not to be used for the diagnosis of chronic obstructive pulmonary disease

or asthma. Its limitations include use in pediatric asthma and is currently under

treatment.

  • Where to Use: This risk assessment tool has

been prepared for use in preventive pulmonary screening programs at

outpatient clinics, emergency rooms, and health check clinics specifically

looking at chronic obstructive pulmonary disease.

Preview

4 images
Apollo Hospitals AICOPD preview 1Apollo Hospitals AICOPD preview 2Apollo Hospitals AICOPD preview 3Apollo Hospitals AICOPD preview 4

Agent build and provenance

Sign in to see the provenance.

The evidence, the layer-by-layer tracing, the risk basis, and the cross-marketplace links are open to signed-in accounts.

Sign in

Compliance

Government
  • FedRAMPConfirmedNot listed90%, registry-checkedNo FedRAMP Marketplace entry matched this vendor's domain, checked 2026-08-27registry recordas observed 2026-08-27

Confirmed means matched to a public authoritative registry. Claimed means the vendor or its listing states it, not yet cross-checked. A framework not shown was not found in any source we hold, which is not evidence against it. Not listed means a scoped registry check found no match for this vendor's domain: a No is a scoped registry check, not a compliance judgment. Confidence bands: 95% domain-verified, 90% registry-checked, 80% self-attested, 70% weak signal. Self-attested items marked “vendor's site” are gathered from the vendor's own website and are not verified by us.

Vendor

External enrichment · as of 2026-08-07

CompanyApollo Hospitals Enterprise LimitedAutomated
HQIndiaAutomated
IndustryHealth CareAutomated
Websitehttps://www.apollohospitals.com/

Plans and pricing as listed

1 listed
AICOPD Subscription Plan
  • API Call Details/Unit Price: $3.65 per api call
$31,390.00/month
AICOPD Subscription Plan

Sources

Marketplace listingmarketplace.microsoft.comSource
Privacy PolicyPrivacy PolicySource

Publisher resources

3 links
Apollo AICOPD IFUcatalogartifact.azureedge.netSource
Apollo AICOPD walkthrough videowww.youtube.comSource
Pricing
Paid
1 plan listed
Delivery
SaaS
https://clinical-ai-apps.apollohospitals.com/
Open the source listing ↗

Evidence risk is the share of the build you cannot see before you deploy, not a security rating. Sign in to see the layer-by-layer basis for this band.